Cerebral Hypoxia Clinical Trials

Find Cerebral Hypoxia Clinical Trials Near You

The Effect of Blood Carboxyhemoglobin Levels on NF-kB, NRF2 and PGC-1α During Low-flow and Normal-flow Anesthesia

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Carbon monoxide (CO) is a colorless, odorless, and tasteless gas that exerts diverse biological effects across tissues and organs. At high concentrations, it is recognized as toxic because of harmful effects such as tissue hypoxia, oxidative stress, peroxynitrite formation, inflammation, apoptosis, and immune damage. However, the endogenous production of CO suggests that it may confer protective mechanisms to the host. These protective effects include inhibition of platelet activation, smooth muscle relaxation, vasoactive properties, anti-inflammatory and anti-apoptotic actions, and beneficial influences on neurotransmission. Despite its toxic potential, low-concentration endogenous CO may provide protection linked to the body's defense mechanisms. In this study, we aimed to investigate the anti-apoptotic effects of carbon monoxide at low concentrations. To this end, the relationships between COHb levels and plasma levels of NF-κB, NRF2, and PGC-1α were analyzed statistically.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• aged 18-70 years

• classified as ASA I

• scheduled for inhalational anesthesia lasting ≥2 hours

Locations
Other Locations
Turkey
Veysel
RECRUITING
Erzurum
Time Frame
Start Date: 2026-02-20
Estimated Completion Date: 2026-08-31
Participants
Target number of participants: 120
Treatments
Experimental: COHb
Experimental: TAS
Experimental: TOS
Experimental: HIF 1a
Related Therapeutic Areas
Sponsors
Leads: Ataturk Training and Research Hospital

This content was sourced from clinicaltrials.gov